Concepedia

Thomas A. Paul

TA

Statistics

Publications

21

Citations

1.8K

H-Index

16

Active since

2001

Affiliations

Pfizer (United States)(Current)

National Cancer Institute

Cornell University

University of Tübingen

Monash University

Thomas A. Paul is an author at Pfizer (United States) specializing in oncology, molecular biology, and molecular oncology.

ORCID

Publications per year

2001–2025

21

Publications

21

Tumor Lymphangiogenesis

Soheil S. Dadras, Thomas A. Paul, Jennifer Bertoncini et al. · American Journal Of Pathology · 2003 · 480 citations · Full text

Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer

Liron Bar‐Peled, Esther K. Kemper, Radu M. Suciu et al. · Cell · 2017 · 288 citations · Full text

, , +12

The SMARCA2/4 ATPase Domain Surpasses the Bromodomain as a Drug Target in SWI/SNF-Mutant Cancers: Insights from cDNA Rescue and PFI-3 Inhibitor Studies

Bhavatarini Vangamudi, Thomas A. Paul, Parantu K. Shah et al. · Cancer Research · 2015 · 270 citations

, , +13

Quantitative Analysis of Herpesvirus Sequences from Normal Tissue and Fibropapillomas of Marine Turtles with Real-Time PCR

Sandra L. Quackenbush, Rufina N. Casey, Rebecca J. Murcek et al. · Virology · 2001 · 116 citations

, , +17

Signatures of polycomb repression and reduced H3K4 trimethylation are associated with p15INK4b DNA methylation in AML

Thomas A. Paul, Juraj Bies, Donald Small et al. · Blood · 2010 · 84 citations

, , +16

1–5 of 21